NCT00791635Active, not recruiting
Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer
Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
The study investigates whether certain characteristics of gynecological cancer can help researchers predict how well a patient recovers from surgery to remove the lower colon, rectum, and bladder, and create openings through which urine and stool are passed out of the body (pelvic exenteration). Comparing the types of surgery completed and procedures used may help researchers to determine which are most effective and safe in patients with a history of gynecologic cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 79 (actual)
- First submitted
- 13 Nov 2008
- Start date
- 11 Jul 2008
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Endometrial cancer, Cervical cancer
- NCT number
- NCT00791635
What you commit to
- Study type: Observational
- Participants enrolled: 79
- From 11 Jul 2008 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with contraindications to surgery
Other
- Patients unwilling or unable to complete self-administered questionnaires
- Patients who do not read or speak English or Spanish
Who the study is looking for
- Women with a history of gynecologic malignancy, including cervical, endometrial, vulvar, or vaginal carcinoma of any histology
- Women who have undergone a pelvic exenteration after January 1993 or who are being offered a pelvic exenteration for treatment of their gynecologic malignancy
- Patients must be suitable candidates for surgery (in case of prospective collection)
- Patients who have signed an approved informed consent
- Patients with a prior malignancy allowed if \> 3 years previous with no current evidence of disease
- Women must be able to read and write in either Spanish or English
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.